SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cavitation Technologies, Inc. – ‘10-Q’ for 12/31/23 – ‘EX-101.SCH’

On:  Wednesday, 2/14/24, at 10:16am ET   ·   For:  12/31/23   ·   Accession #:  1683168-24-947   ·   File #:  0-53239

Previous ‘10-Q’:  ‘10-Q’ on 11/1/23 for 9/30/23   ·   Next & Latest:  ‘10-Q’ on 5/15/24 for 3/31/24   ·   11 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/14/24  Cavitation Technologies, Inc.     10-Q       12/31/23   44:2.3M                                   GlobalOne Filings Inc/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Form 10-Q for Dec 2023                              HTML    426K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     17K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     17K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     14K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     14K 
11: R1          Cover                                               HTML     61K 
12: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    104K 
13: R3          Condensed Consolidated Balance Sheets (Unaudited)   HTML     35K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Operations     HTML     70K 
                (Unaudited)                                                      
15: R5          Condensed Consolidated Statements of Operations     HTML     32K 
                (Unaudited) (Parenthetical)                                      
16: R6          Condensed Consolidated Statements of Changes in     HTML     40K 
                Stockholders' Deficit (Unaudited)                                
17: R7          Condensed Consolidated Statements of Cash Flows     HTML     63K 
                (Unaudited)                                                      
18: R8          Organization and Summary of Significant Accounting  HTML     50K 
                Policies                                                         
19: R9          Contracts with Desmet Ballestra Group               HTML     23K 
20: R10         Investment in equity method investment              HTML     23K 
21: R11         Operating Lease                                     HTML     32K 
22: R12         Related Party Transactions                          HTML     22K 
23: R13         Notes Payable                                       HTML     24K 
24: R14         Stockholders' Equity                                HTML     46K 
25: R15         Commitments and Contingencies                       HTML     20K 
26: R16         Organization and Summary of Significant Accounting  HTML     66K 
                Policies (Policies)                                              
27: R17         Organization and Summary of Significant Accounting  HTML     22K 
                Policies (Tables)                                                
28: R18         Operating Lease (Tables)                            HTML     32K 
29: R19         Stockholders' Equity (Tables)                       HTML     42K 
30: R20         Organization and Summary of Significant Accounting  HTML     21K 
                Policies (Details)                                               
31: R21         Organization and Summary of Significant Accounting  HTML     56K 
                Policies (Details Narrative)                                     
32: R22         Contracts with Desmet Ballestra Group (Details      HTML     31K 
                Narrative)                                                       
33: R23         Investment in equity method investment (Details     HTML     26K 
                Narrative)                                                       
34: R24         Operating Lease (Details - Lease Cost)              HTML     32K 
35: R25         Operating Lease (Details - Operating Lease Minimum  HTML     24K 
                payments)                                                        
36: R26         Related Party Transactions (Details Narrative)      HTML     19K 
37: R27         Notes Payable (Details Narrative)                   HTML     32K 
38: R28         Stockholders' Equity (Details - Warrant activity)   HTML     51K 
39: R29         Stockholders' Equity (Details - Warrants by         HTML     31K 
                exercise price)                                                  
41: XML         IDEA XML File -- Filing Summary                      XML     72K 
44: XML         XBRL Instance -- cavitation_i10q-123123_htm          XML    447K 
40: EXCEL       IDEA Workbook of Financial Report Info              XLSX     59K 
 7: EX-101.CAL  XBRL Calculations -- cvat-20231231_cal               XML     83K 
 8: EX-101.DEF  XBRL Definitions -- cvat-20231231_def                XML    171K 
 9: EX-101.LAB  XBRL Labels -- cvat-20231231_lab                     XML    433K 
10: EX-101.PRE  XBRL Presentations -- cvat-20231231_pre              XML    336K 
 6: EX-101.SCH  XBRL Schema -- cvat-20231231                         XSD     66K 
42: JSON        XBRL Instance as JSON Data -- MetaLinks              226±   325K 
43: ZIP         XBRL Zipped Folder -- 0001683168-24-000947-xbrl      Zip    112K

‘EX-101.SCH’   —   XBRL Schema — cvat-20231231

This Exhibit is an XBRL File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21b -->
<!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
<!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaiJ6aPty5522YkxvmR7fRmaTyQrGPm/iSUMOH+G0c0A -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:CVAT="http://ctinanotech.com/20231231" elementFormDefault="qualified" targetNamespace="http://ctinanotech.com/20231231">
<annotation>
<appinfo>
<link:roleType roleURI="http://ctinanotech.com/role/Cover" id="Cover">
<link:definition> 00000001 - Document - Cover </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
<link:definition> 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
<link:definition> 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/CondensedConsolidatedStatementsOfOperations" id="CondensedConsolidatedStatementsOfOperations">
<link:definition> 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/CondensedConsolidatedStatementsOfOperationsParenthetical" id="CondensedConsolidatedStatementsOfOperationsParenthetical">
<link:definition> 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersDeficit" id="CondensedConsolidatedStatementsOfChangesInStockholdersDeficit">
<link:definition> 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/CondensedConsolidatedStatementsOfCashFlows" id="CondensedConsolidatedStatementsOfCashFlows">
<link:definition> 00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies" id="OrganizationAndSummaryOfSignificantAccountingPolicies">
<link:definition> 00000008 - Disclosure - Organization and Summary of Significant Accounting Policies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/ContractsWithDesmetBallestraGroup" id="ContractsWithDesmetBallestraGroup">
<link:definition> 00000009 - Disclosure - Contracts with Desmet Ballestra Group </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/InvestmentInEquityMethodInvestment" id="InvestmentInEquityMethodInvestment">
<link:definition> 00000010 - Disclosure - Investment in equity method investment </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/OperatingLease" id="OperatingLease">
<link:definition> 00000011 - Disclosure - Operating Lease </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
<link:definition> 00000012 - Disclosure - Related Party Transactions </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/NotesPayable" id="NotesPayable">
<link:definition> 00000013 - Disclosure - Notes Payable </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/StockholdersEquity" id="StockholdersEquity">
<link:definition> 00000014 - Disclosure - Stockholders' Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition> 00000015 - Disclosure - Commitments and Contingencies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" id="OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies">
<link:definition> 00000016 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesTables" id="OrganizationAndSummaryOfSignificantAccountingPoliciesTables">
<link:definition> 00000017 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/OperatingLeaseTables" id="OperatingLeaseTables">
<link:definition> 00000018 - Disclosure - Operating Lease (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/StockholdersEquityTables" id="StockholdersEquityTables">
<link:definition> 00000019 - Disclosure - Stockholders' Equity (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetails" id="OrganizationAndSummaryOfSignificantAccountingPoliciesDetails">
<link:definition> 00000020 - Disclosure - Organization and Summary of Significant Accounting Policies (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" id="OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative">
<link:definition> 00000021 - Disclosure - Organization and Summary of Significant Accounting Policies (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/ContractsWithDesmetBallestraGroupDetailsNarrative" id="ContractsWithDesmetBallestraGroupDetailsNarrative">
<link:definition> 00000022 - Disclosure - Contracts with Desmet Ballestra Group (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/InvestmentInEquityMethodInvestmentDetailsNarrative" id="InvestmentInEquityMethodInvestmentDetailsNarrative">
<link:definition> 00000023 - Disclosure - Investment in equity method investment (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/OperatingLeaseDetails-LeaseCost" id="OperatingLeaseDetails-LeaseCost">
<link:definition> 00000024 - Disclosure - Operating Lease (Details - Lease Cost) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/OperatingLeaseDetails-OperatingLeaseMinimumPayments" id="OperatingLeaseDetails-OperatingLeaseMinimumPayments">
<link:definition> 00000025 - Disclosure - Operating Lease (Details - Operating Lease Minimum payments) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
<link:definition> 00000026 - Disclosure - Related Party Transactions (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/NotesPayableDetailsNarrative" id="NotesPayableDetailsNarrative">
<link:definition> 00000027 - Disclosure - Notes Payable (Details Narrative) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/StockholdersEquityDetails-WarrantActivity" id="StockholdersEquityDetails-WarrantActivity">
<link:definition> 00000028 - Disclosure - Stockholders' Equity (Details - Warrant activity) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://ctinanotech.com/role/StockholdersEquityDetails-WarrantsByExercisePrice" id="StockholdersEquityDetails-WarrantsByExercisePrice">
<link:definition> 00000029 - Disclosure - Stockholders' Equity (Details - Warrants by exercise price) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="cvat-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="cvat-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="cvat-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links"/>
<link:linkbaseRef xlink:type="simple" xlink:href="cvat-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links"/>
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
<import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
<import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
<import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
<import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd"/>
<element id="CVAT_RevenueFromCustomersMember" name="RevenueFromCustomersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_RevenueFromJointVentureMember" name="RevenueFromJointVentureMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_OneVendorMember" name="OneVendorMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_TwoVendorsMember" name="TwoVendorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_DesmetMember" name="DesmetMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_NanoReactorSalesMember" name="NanoReactorSalesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_AmeredevMember" name="AmeredevMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_EIDLLoanMember" name="EIDLLoanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_WarrantPrice1Member" name="WarrantPrice1Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_WarrantPrice2Member" name="WarrantPrice2Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_LossFromEquityMethodInvestments" name="LossFromEquityMethodInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_DisclosureContractsWithDesmetBallestraGroupAbstract" name="DisclosureContractsWithDesmetBallestraGroupAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_ContractWithDesmetBallestraTextBlock" name="ContractWithDesmetBallestraTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_DisclosureOperatingLeaseAbstract" name="DisclosureOperatingLeaseAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_GoingConcernPolicyTextBlock" name="GoingConcernPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_ScheduleOfWarrantsOutstandingAndExercisableTableTextBlock" name="ScheduleOfWarrantsOutstandingAndExercisableTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_ContractWithCustomerLiabilityDescription" name="ContractWithCustomerLiabilityDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExpiredInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExpiredInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisableNumber" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item"/>
<element id="CVAT_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisableWeightedAverageRemainingContractualTerm1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisableWeightedAverageRemainingContractualTerm1" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item"/>
</schema>

11 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/15/12  Cavitation Technologies, Inc.     10-K        6/30/12   35:4M                                     Meyer Harol… Gretchen/FA
11/10/11  Cavitation Technologies, Inc.     10-Q        9/30/11   33:4.3M                                   Meyer Harol… Gretchen/FA
10/20/11  Cavitation Technologies, Inc.     10-K/A      6/30/09   28:36M                                    Toppan Merrill/FA
 9/28/11  Cavitation Technologies, Inc.     10-K        6/30/11   18:25M                                    Toppan Merrill/FA
 2/11/11  Cavitation Technologies, Inc.     10-Q       12/31/10    9:9.8M                                   Toppan Merrill/FA
 5/18/10  Cavitation Technologies, Inc.     8-K:1,9     5/13/10    5:6.4M                                   Toppan Merrill/FA
11/16/09  Cavitation Technologies, Inc.     10-Q        9/30/09    6:750K                                   Toppan Merrill/FA
10/29/09  Cavitation Technologies, Inc.     8-K:5      10/29/09    1:28K                                    Toppan Merrill/FA
 5/14/09  Cavitation Technologies, Inc.     10-Q        3/31/09    6:757K                                   Toppan Merrill/FA
 2/17/09  Cavitation Technologies, Inc.     10-Q       12/31/08    6:1M                                     Toppan Merrill/FA
10/19/06  Cavitation Technologies, Inc.     SB-2       10/18/06    8:480K                                   Newsfile Corp./FA
↑Top
Filing Submission 0001683168-24-000947   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Thu., May 16, 7:30:39.1pm ET